The estimated Net Worth of Christopher Krawtschuk is at least $46.8 ezer dollars as of 6 December 2023. Christopher Krawtschuk owns over 4,526 units of Bluebird bio Inc stock worth over $26,375 and over the last 2 years Christopher sold BLUE stock worth over $20,458.
Christopher has made over 1 trades of the Bluebird bio Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently Christopher sold 4,526 units of BLUE stock worth $20,458 on 6 December 2023.
The largest trade Christopher's ever made was selling 4,526 units of Bluebird bio Inc stock on 6 December 2023 worth over $20,458. On average, Christopher trades about 1,509 units every 0 days since 2022. As of 6 December 2023 Christopher still owns at least 45,474 units of Bluebird bio Inc stock.
You can see the complete history of Christopher Krawtschuk stock trades at the bottom of the page.
Christopher's mailing address filed with the SEC is C/O BLUEBIRD BIO, INC, 455 GRAND UNION BOULEVARD, SOMERVILLE, MA, 02145.
Over the last 11 years, insiders at Bluebird bio Inc have traded over $130,743,125 worth of Bluebird bio Inc stock and bought 6,469 units worth $399,874 . The most active insiders traders include Steven Gillis, John Maraganore és Robert I Tepper. On average, Bluebird bio Inc executives and independent directors trade stock every 8 days with the average trade being worth of $6,033. The most recent stock trade was executed by Thomas J Klima on 3 June 2024, trading 3,834 units of BLUE stock currently worth $3,719.
we are leading the gene therapy revolution. our integrated product platforms encompass gene therapy, cancer immunotherapy and gene editing – providing us with the potential to treat, and hopefully cure, a broad range of serious diseases. we have a lot of energy, and it’s not just the abundance of coffee that keeps us going. find out what sparks our excitement and inspires us every day.
Bluebird bio Inc executives and other stock owners filed with the SEC include: